Skip to content
★ Sign in to follow
AP

Albert Patterson

Executive
Sagent Pharmaceuticals, Inc.
Total declarations
21
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 22 Mar 2016 for Sagent Pharmaceuticals, Inc., €723.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Albert Patterson: trading record in brief

Albert Patterson appears in our data through filings on Sagent Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 22 February 2012 to 19 March 2016, the count stands at 21 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 22 March 2016, reports a share grant of €723 in Sagent Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Albert Patterson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total

20 of 20 declarations